Orris

Explain me prostate cancer. I need to study this for my urology class. Our proffoser asks questions like we are doctors in urology speciality for 10yrs. I hope you understand how deep he asks questions. So explain everything about prostate cancer to me. Some of the things that you can't miss are Classification, Etiology, pathogenesis, symptoms and signs (where, how,severity etc etc), diagnosis, clinical manifestations, prognosis, treatment. These are some must give details you have to give me more information than this. Understood?

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Searching Images

prostate cancer Gleason grading histology adenocarcinoma

Reading File
Reading File
Searching Images

prostate cancer TNM staging bone metastases osteoblastic

Reading File
Reading File
Reading File
Reading File
Searching PubMed

prostate cancer treatment guidelines 2024

That covers everything your professor is likely to ask at a 10-year urology specialist level. Here's a quick map of what was covered so you can navigate:
What you just got — section by section:
  1. Epidemiology — incidence, mortality, racial/ethnic disparities, autopsy prevalence
  2. Etiology & Risk Factors — family history, germline mutations (BRCA2, HOXB13, ATM), GWAS loci, diet, obesity, protective factors
  3. Anatomy & Zones — why peripheral zone matters; contrast with BPH in transition zone
  4. Pathogenesis — androgen/DHT/AR axis, TMPRSS2:ERG fusion, PTEN loss, AR mutations in CRPC, HGPIN as precursor
  5. Pathology & Classification — histologic subtypes, gross/microscopic features, IHC markers (AMACR, p63, CK5), perineural invasion
  6. Gleason Grading — patterns 1–5, grade groups 1–5 with descriptions, tertiary pattern rule
  7. TNM Staging — full AJCC 8th edition clinical + pathological, risk stratification table
  8. Clinical Manifestations — asymptomatic localized → LUTS → bone pain → spinal cord compression; lymphatic then hematogenous spread order; osteoblastic nature of bone mets
  9. Diagnosis — PSA and all derivatives (PHI, 4K Score, free PSA), DRE, mpMRI/PI-RADS, biopsy techniques, PSMA PET, labs, germline/somatic testing
  10. Clinical States Model — the modern framework (localized → BCR → nmCRPC → mHSPC → mCRPC)
  11. Treatment — active surveillance, radical prostatectomy, radiation (EBRT/brachytherapy/SBRT), ADT mechanisms and agents, treatment intensification for mHSPC (ARPI, docetaxel, triplet), mCRPC therapies (taxanes, PARP inhibitors, lutetium-PSMA, Ra-223), nmCRPC
  12. Prognosis — nomograms, Partin tables, PSA doubling time, 5-year survival by stage
  13. Genomic Testing — Oncotype GPS, Decipher, Prolaris, MSI/BRCA testing
  14. Screening Guidelines — AUA 2023, USPSTF, EAU 2024
The two most frequently tested "exam traps" at this level: the distinction between clinical vs. pathological T1 (pT1 does not exist in the surgical specimen), and the fact that Gleason score 6 is the minimum assigned today — patients mistakenly think it's "middle of the scale."
This is a shared conversation. Sign in to Orris to start your own chat.